Investing Profile

Clare Ozawa

VCInvestor
Managing Director at Versant Ventures
Photo of Clare Ozawa, Managing Director at Versant Ventures
cb
Versant Ventures Managing Director
$100K - $5.0M
$1.5M
12
$102.2M
CompanyStageDateRound SizeTotal Raised
858 Therapeutics
Series BSep 2024$50M
Series ASep 2021$60M
$110M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Gate Bioscience
Series ANov 2023$60M
$60M
Co-investors: Scott Biller (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Jay Parrish (ARCH Venture Partners)
Kate Therapeutics
Series AJun 2023$51M
$51M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Lycia Therapeutics
Series BSep 2021$70M
$70M
Co-investors: Jeremy Caldwell (Versant Ventures)
LENZ Therapeutics
Series AJun 2021$47M
$47M
Co-investors: Zach Scheiner (RA Capital)
Capsida
Series AApr 2021$50M
$50M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Pipeline Therapeutics
Series CFeb 2021$80M
Series BDec 2019$32M
$110M
Co-investors: Paul Grayson (Versant Ventures)
Oyster Point Pharmaceuticals
Series BFeb 2019$93M
Series ANov 2017$22M
Series ANov 2017$29M
$140M